Article Information
History
- July 11, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 11, 2020 - 15:30).
- Version 2 (July 14, 2020 - 14:36).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Umesha Boregowda, MD1,*,
- Abhilash Perisetti, MD, FACP2,
- Arpitha Nanjappa, MD1,
- Mahesh Gajendran, MD, MPH, FACP4 and
- Hemant Goyal, MD, MD FACP PGDCA (MBA)5
- 1Department of Medicine, Bassett Medical Center, 1 Atwell Road, Cooperstown NY 13326, Office: 607-547-4586
- 2Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
- 4Department of Internal Medicine, Texas Tech University, Paul L Foster School of Medicine, El Paso, Texas 79905, United States. Phone number: 915-215-8000, Fax Number: 915-612-9254
- 5The Wright Center for Graduate Medical Education, 501 S. Washington Avenue, Scranton, PA 18503, Office: 570-591-5175
- ↵*Corresponding author:
Umesha Boregowda, MD, Department of Medicine, Bassett Medical Center, 1 Atwell Road, Cooperstown NY 13326, Office: 607-547-4586, Email: umeshanb007{at}gmail.com
Contributions: Conception and design: Umesha Boregowda, Hemant Goyal
Posted July 11, 2020.
Addition of Tocilizumab to standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis
